MetaVia completes dose titration in Phase 1 Part 3 obesity trial

July 9, 2026 8:31 AM

MetaVia Inc. (Nasdaq: MTVA) announced that all active patients enrolled in Part 3 of its Phase 1 clinical trial evaluating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found